Pro-Dex, Inc. (PDEX) vs Stereotaxis Inc. (STXS)

Pro-Dex, Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Pro-Dex, Inc. is the larger, with a market value of $233.9M against $133.3M — 1.8× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 17.0×. Pro-Dex, Inc. grew revenue faster over the last twelve months: 16.5% against −5.46%. Pro-Dex, Inc. has the higher net margin (17.6% vs −78.5%) and the higher return on invested capital (15.8% vs −203.6%). Across the 19 metrics below, Pro-Dex, Inc. leads on 17 and Stereotaxis Inc. on 2.

Valuation

Metric PDEX STXS Medical Instruments & Supplies median
P/E 16.97 n/m 34.17
P/S 2.99 4.32 2.83
P/B 4.86 10.62 2.82
Price to free cash flow 34.42 n/m 25.69
EV/EBITDA 16.35 n/m 16.08
EV/Sales 3.04 4.16 3.06
Earnings yield 5.89% (18.46%) (1.84%)
Free cash flow yield 2.91% (11.92%) 0.17%

Profitability

Metric PDEX STXS Medical Instruments & Supplies median
Gross margin 31.38% 55.57% 54.62%
Operating margin 16.75% (75.68%) 1.64%
Net margin 17.62% (78.45%) 0.00%
Free cash flow margin 8.72% (51.56%) 1.61%
Return on equity 32.43% (344.36%) 0.00%
Return on assets 20.14% (48.76%) 0.00%
Return on invested capital 15.75% (203.58%) 0.00%

Growth

Metric PDEX STXS Medical Instruments & Supplies median
Revenue growth (TTM) 16.45% (5.46%) 9.20%
EPS growth (last fiscal year) 54.31% 16.67% —
Revenue growth, 5-year CAGR 15.32% 3.99% 9.48%
Net income growth, 5-year CAGR 17.23% 0.00% 0.00%

Health

Metric PDEX STXS Medical Instruments & Supplies median
Debt to equity 0.28 0.00 0.08
Current ratio 4.10 1.42 2.49
Net debt to EBITDA 0.27 0.65 0.83

Dividend

Metric PDEX STXS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric PDEX STXS Medical Instruments & Supplies median
Market cap 233.91m 133.27m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack